Pharmaron held the 5th Pharmaron Symposium in Synthetic and Medicinal Chemistry
BEIJING – September 12, 2015 Pharmaron held the 5th Pharmaron Symposium in Synthetic and Medicinal Chemistry in Beijing. This Symposium featured seven presentations by world sought-after leaders from both academia and biopharmaceutical industry, showcasing recent advances of innovation in synthetic and medicinal chemistry, from highly creative approaches to synthetic and medicinal chemistry challenges, to creation of novel concepts. These novel approaches and concepts will have significant impact on the future of synthetic and medicinal chemistry. The beautiful science and effective drug R&D technologies as presented by the speakers with high energy, stimulated great discussions between the speakers and symposium attendees. The Symposium also served as a training platform to strengthen Pharmaron’s integrated R&D abilities, gained additional insight about the development of the industry, and deepened understanding of synthetic and medicinal chemistry.
Featured Speakers:
Prof. F Dean Toste
Department of Chemistry,
University of California, Berkeley,
USA
Dr. David M. Wilson
Senior Director and Head,
Oncology iMED Medicinal Chemistry, AstraZeneca,
UK
Dr. Christopher H. Hill
Vice President, Head of Discovery
Chemistry, MSD,
USA
Dr. Hing Leung Sham
Senior Vice President,
Global Blood Therapeutics,
USA
Prof. Ang Li
State Key Laboratory of Bioorganic and Natural Product Chemistry,
Shanghai Institute of Organic Chemistry,
China
Prof. Xiaoming Feng
Key Laboratory of Green Chemistry & Technology,
College of Chemistry, Sichuan University,
China
Prof. Erick M. Carreira
Department of Chemistry and Applied Biosciences,
ETH Zurich,
Switzerland